• Non ci sono risultati.

Ernst Schering Research Foundation Workshop 62 PET Chemistry

N/A
N/A
Protected

Academic year: 2021

Condividi "Ernst Schering Research Foundation Workshop 62 PET Chemistry"

Copied!
11
0
0

Testo completo

(1)

Ernst Schering Research Foundation Workshop 62 PET Chemistry

(2)

Ernst Schering Research Foundation Workshop 62

PET Chemistry

The Driving Force in Molecular Imaging

P.A. Schubiger, L. Lehmann, M. Friebe Editors

With 140 Figures and 20 Tables

123

(3)

Series Editors: G. Stock and M. Lessl

Library of Congress Control Number: 2006927239 ISSN 0947-6075

ISBN-10 3-540-32623-5 Springer Berlin Heidelberg New York ISBN-13 978-3-540-32623-6 Springer Berlin Heidelberg New York

This work is subject to copyright. All rights are reserved, whether the whole or part of the material is concerned, specifically the rights of translation, reprinting, reuse of illustrations, recitation, broadcasting, reproduction on microfilms or in any other way, and storage in data banks. Duplication of this publication or parts thereof is permitted only under the provisions of the German Copyright Law of September 9, 1965, in its current version, and permission for use must always be obtained from Springer-Verlag. Violations are liable for prosecution under the German Copyright Law.

Springer is a part of Springer Science+Business Media springer.com

© Springer-Verlag Berlin Heidelberg 2007

The use of general descriptive names, registered names, trademarks, etc. in this publication does not emply, even in the absence of a specific statemant, that such names are exempt from the relevant protective laws and regulations and therefor free for general use. Product liability: The publisher cannot guarantee the accuracy any information about dosage and application contained in this book. In every induvidual case the user must check such information by consulting the relevant literature.

Editor: Dr. Ute Heilmann, Heidelberg Desk Editor: Wilma McHugh, Heidelberg Production Editor: Monika Riepl, Leipzig Cover design: WMXDesign GmbH, Heidelberg

Typesetting and production: LE-TEX Jelonek, Schmidt & Vöckler GbR, Leipzig 21/3100/YL – 5 4 3 2 1 0 Printed on acid-free paper

(4)

Preface

Personalized medicine employing patient-based tailor-made therapeutic drugs is taking over treatment paradigms in a variety of fields in oncology and the central nervous system. The success of such therapies is mainly dependent on efficacious therapeutic drugs and a selective imaging probe for identification of potential responders as well as therapy monitoring for an early benefit assessment. Molecular imaging (MI) is based on the selective and specific interaction of a molecular probe with a biological target which is visualized through nuclear, magnetic resonance, near infrared or other methods. Therefore it is the method of choice for patient selection and therapy monitoring as well as for specific end- point monitoring in modern drug development. PET (positron emitting tomography), a nuclear medical imaging modality, is ideally suited to produce three-dimensional images of various targets or processes. The rapidly increasing demand for highly selective probes for MI strongly pushes the development of new PET tracers and PET chemistry.

‘PET chemistry’ can be defined as the study of positron-emitting compounds regarding their synthesis, structure, composition, reactivity, nuclear properties and processes and their properties in natural and un- natural environments. In practice PET chemistry is strongly influenced by the unique properties of the radioisotopes used (e.g., half-life, chemi- cal reactivity, etc.) and integrates scientific aspects of nuclear-, organic-, inorganic- and biochemistry.

(5)

VI Preface The 62nd Ernst Schering Foundation Workshop ‘PET Chemistry – The Driving Force in Molecular Imaging’ is the first in the history of the Foundation devoted to special aspects of the synthesis and characteriza- tion of PET tracers. The purpose of the workshop was to gain a deeper insight into the complex applications and emerging technologies in the area of PET chemistry. New inventions in this field have a strong impact on MI, preclinical and clinical research, new therapeutic drug develop- ment, clinical routine applications and new chemical concepts.

The contributions from the invited experts that are compiled in this book demonstrate the focus and the large investment of effort over the last decade towards the advancement of PET chemistry as the cornerstone of MI today. New ideas in this exciting field translate into practical benefit very quickly. Scientific aspects covered by the workshop included re- flections on a variety of PET isotopes such as11C,68Ga,64Cu,86Y,76Br,

77Br,124I and their impact on the MI field. The main focus was put on

18F, the ‘workhorse’ of PET. The contributions embraced a broad spec- trum of new technical features such as the application of microwaves, microreactors and modules in the synthesis and development of new PET tracers.

The open atmosphere that prevailed during interdisciplinary discus- sions, and the dedication towards the goal of advancing the shared field of expertise, led to a profound contribution to PET chemistry.

We wish to express our sincere gratitude to all participants for their contributions to both the workshop and to this book. We are also grateful to the Schering Research Foundation for the generous support in making the workshop a great success.

Berlin, May 2006, August Schubiger Lutz Lehman Matthias Friebe

(6)

Contents

1 Molecular Imaging with PET – Open Questions?

P.A. Schubiger . . . . 1 2 Fluorine-18 Labeling Methods: Features and Possibilities

of Basic Reactions

H.H. Coenen . . . . 15 3 Fluorine-18 Labeling of Small Molecules:

The Use of18F-Labeled Aryl Fluorides Derived

from No-Carrier-Added [18F]Fluoride as Labeling Precursors F. Wuest . . . . 51 4 Fluorine-18 Labeling of Peptides and Proteins

H.J. Wester, M. Schottelius . . . . 79 5 [18F]Fluoropyridines: From Conventional Radiotracers

to the Labeling of Macromolecules Such as Proteins and Oligonucleotides

F. Dollé . . . . 113 6 Production of Non-standard PET Radionuclides

and the Application of Radiopharmaceuticals Labeled with these Nuclides

M.J. Welch, R. Laforest, J.S. Lewis . . . . 159

(7)

VIII Contents 7 Carbon-11 Labeling Chemistry

Based upon [11C]Methyl Iodide

F. Wuest, M. Berndt, T. Kniess . . . . 183 8 68Ga-PET Radiopharmacy: A Generator-Based Alternative

to18F-Radiopharmacy

H.R. Maecke, J.P. André . . . . 215 9 Microwaving in F-18 Chemistry:

Quirks and Tweaks

S. Stone-Elander, N. Elander, J.-O. Thorell,

A. Fredriksson . . . . 243 10 Micro-reactors for PET Tracer Labeling

S.Y. Lu, V.W. Pike . . . . 271 11 Synthesis Modules and Automation in F-18 Labeling

R. Krasikova . . . . 289 12 Pharmacological Prerequisites for PET Ligands

and Practical Issues in Preclinical PET Research

S.M. Ametamey, M. Honer . . . . 317 13 Positron Emission Tomography Imaging

as a Key Enabling Technology in Drug Development

T.J. McCarthy . . . . 329 Previous Volumes Published in This Series . . . . 341

(8)

List of Editors and Contributors

Editors

Schubiger, P.A.

Animal Imaging Center – PET, Center for Radiopharmaceutical Science of ETH, PSI and USZ, ETH Hönggerberg D-CHAB, Wolfgang-Pauli Str. 10, 8093 Zürich, Switzerland

(e-mail: august.schubiger@pharma.ethz.ch)

Friebe, M.

Corporate Research, Schering AG, Müller Str. 178, 13342 Berlin, Germany (e-mail: matthias.friebe@schering.de)

Lehmann, L.

Corporate Research, Schering AG, Müller Str. 178, 13342 Berlin, Germany (e-mail: lutz.lehmann@schering.de)

Contributors

Ametamey, S.M.

Animal Imaging Center-PET, Center for Radiopharmaceutical Science of ETH, PSI and USZ, ETH-Hönggerberg, D-CHAB, Wolfgang-Pauli-Str. 10, 8093 Zürich, Switzerland

(e-mail: simon.ametamey@pharma.ethz.ch)

André, J. P.

Centro de Química, Campus de Gultar, Universidade do Minho, 4710-057 Braga, Portugal

(9)

X List of Editors and Contributors

Berndt, M.

PET Tracer Department, Institute of Bioinorganic and Radiopharmaceutical Chemistry, Research Centre Rossendorf, P.O. Box 510119, 01328 Dresden, Germany

Coenen, H.H.

Institut für Nuklearchemie (INC), Forschungszentrum Jülich GmbH, Wilhelm-Johnen-Str., 52425 Jülich, Germany

(e-mail: h.h.coenen@fz-juelich.de)

Dollé, F.

Service Hospitalier Frédéric Joliot, Département de Recherche Médicale – CEA, 4 Place du Général Leclerc, 91406 Orsay, France

(e-mail: frederic.dolle@cea.fr)

Elander, N.

Department of Physics, Albanova Center for Physics, Astronomy and Biotechnology, Stockholm University, 10691 Stockholm, Sweden

Fredriksson, A.

Karolinska Pharmacy Research Department, Karolinska University Hospital, 17176 Stockholm, Sweden

Honer, M.

Center for Radiopharmaceutical Science of ETH, PSI and USZ, Department of Chemistry and Applied Biosciences, ETH-Hönggerberg D-CHAB, Wolfgang-Pauli-Str. 10, 8093 Zürich, Switzerland

Kniess, T.

PET Tracer Department, Institute of Bioinorganic and Radiopharmaceutical Chemistry, Research Centre Rossendorf, P.O. Box 510119, 01328 Dresden, Germany

Krasikova, R.

Institute of the Human Brain, Russian Academy of Science, 9 Pavlov Str., 197376 St. Petersburg, Russia

(e-mail: raisa@ihb.spb.ru)

(10)

List of Editors and Contributors XI

Laforest, R.

Division of Radiological Sciences, Department of Radiology, Mallinckrodt Institute of Radiology, Washington University School of Medicine, 510 South Kingshighway Blvd., St. Louis, MO 63110, USA

Lewis, J.S.

Division of Radiological Sciences, Department of Radiology, Mallinckrodt Institute of Radiology, Washington University School of Medicine, 510 South Kingshighway Blvd., St. Louis, MO 63110, USA

Lu, S.Y.

PET Radiopharmaceutical Sciences, Molecular Imaging Branch, National Institute of Mental Health, NIH, Building 10, Room B3C346, 10 Center Drive, MSC1003, Bethesda, MA 20892-1003, USA (e-mail: ShuiyuLu@mail.nih.gov)

McCarthy, T.J.

Pfizer Global Research and Development, 49 Hancock Dr., Mystic, CT 06355, USA (e-mail: timothy.j.mccarthy@pfizer.com)

Maecke, H.R.

Division of Radiological Chemistry, University Hospital Basel, 4031 Basel, Switzerland

(e-mail hmaecke@uhbs.ch)

Pike, V.W.

PET Radiopharmaceutical Sciences, Molecular Imaging Branch, National Institute of Mental Health, NIH, Building 10, Room B3C346, 10 Center Drive, MSC1003, Bethesda, MA 20892-1003, USA

Schottelius, M.

Nuklearmedizinische Klinik und Poliklinik und Institut für Radiochemie, Technische Universität München, Ismaninger Str. 22, 81675 Munich, Germany

Stone-Elander, S.

Department of Clinical Neuroscience, Positron Emission Tomography, Karolin- ska Pharmacy, Karolinska University Hospital, 17176 Stockholm, Sweden (e-mail: sharon.stone-elander@karolinska.se)

(11)

XII List of Editors and Contributors

Thorell, J.-O.

Karolinska Pharmacy Research Department, Karolinska University Hospital, 17176 Stockholm, Sweden

Welch, M.J.

Division of Radiological Sciences, Department of Radiology, Mallinckrodt Institute of Radiology, Washington University School of Medicine, 510 South Kingshighway Blvd., St. Louis, MO 63110, USA (e-mail: WelchM@mir.wustl.edu)

Wester, H. J.

Nuklearmedizinische Klinik und Poliklinik und Institut für Radiochemie, Technische Universität München, Ismaninger Str. 22, 81675 Munich, Germany (e-mail: H.J.Wester@lrz.tum.de)

Wuest, F.

PET Tracer Department, Institute of Bioinorganic and Radiopharmaceutical Chemistry, Research Centre Rossendorf,

P.O. Box 510119, 01328 Dresden, Germany (e-mail: f.wuest@fz-rossendorf.de)

Riferimenti

Documenti correlati

A prospective evaluation of positron emission tomography scanning, sentinel lymph node biopsy, and standard axillary dis- section for axillary staging in patients with early

Prospective study of fluorodeoxyglucose- positron emission tomography imaging of lymph node basins in melanoma patients undergoing sentinel node biopsy.. Crippa F, Leutner M, Belli

The potential roles for diagnostic imaging of prostate cancer include diagnosis of primary disease, de- termination of extracapsular spread, and detection of lo- coregional lymph

The usefulness of FDG positron emission tomography for the detection of mediastinal lymph node metastases in patients with non-small cell lung cancer: a comparative study with

Insel, the director of the National Institute of Mental Health, announced on Tuesday that he planned to step down in November, ending his 13-year tenure at the helm of the world’s

33 (2001): Stem Cells from Cord Blood, In Utero Stem Cell Development, and Transplantation-Inclusive Gene Therapy Editors: W.Holzgreve,

Centre for Infectious Diseases and International Health, Windeyer Institute of Medical Sciences, Royal Free and University College Medical School, 46Cleveland Street, London W1P 6DB,

Center for Molecular Imaging Research, Building 149, Massachusetts General Hospital, 13th Street, Charleston, MA 02129, USA.. e-mail: abogdanov@helix.mgh.harvard.edu